PMA P060011S039

Device
RayOne EMV Toric
Applicant
Rayner Intraocular Lenses , Ltd.
PMA number
P060011
Supplement
S039
Product code
HQL
Decision date
2025-10-09
Classification
Ophthalmic
Generic name
intraocular lens
Approval order statement
premarket approval application (PMA) supplement for the RayOne EMV Toric (Model RAO210T) consists of the EMV Toric IOL (210T) preloaded within the RayOne injection system (RAO). The EMV Toric IOL is intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia, in adult patients in whom a cataractous lens has been removed by phacoemulsification and providing reduction of residual refractive astigmatism in adult patients with greater than or equal to 1.00 diopter (D) of corneal astigmatism. The RayOne injection system is used to fold and assist in inserting the IOL into the eye.

Current openFDA PMA Record#

Device
RayOne EMV Toric
Applicant
Rayner Intraocular Lenses , Ltd.
PMA number
P060011
Supplement
S039
Product code
HQL
Generic name
intraocular lens
Decision date
2025-10-09
Decision code
APPR
Date received
2025-03-17
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
premarket approval application (PMA) supplement for the RayOne EMV Toric (Model RAO210T) consists of the EMV Toric IOL (210T) preloaded within the RayOne injection system (RAO). The EMV Toric IOL is intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia, in adult patients in whom a cataractous lens has been removed by phacoemulsification and providing reduction of residual refractive astigmatism in adult patients with greater than or equal to 1.00 diopter (D) of corneal astigmatism. The RayOne injection system is used to fold and assist in inserting the IOL into the eye.